News

Kura Oncology Announces Promising Results with Ziftomenib

Kura Oncology Announces Promising Results with Ziftomenib

Exciting Advances in Acute Myeloid Leukemia Treatment

Kura Oncology, Inc. (NASDAQ: KURA) and Kyowa Kirin Co., Ltd. have recently announced promising results from their ongoing clinical trial for the innovative drug ziftomenib. This once-daily, oral investigational drug is paving the way for effective treatments in acute myeloid leukemia (AML). The results will be presented during the upcoming American Society of Hematology (ASH) 2025 Annual Meeting, which is set to take place in December.

Details of the KOMET-007 Trial

The KOMET-007 trial is a Phase 1a/b study that evaluates ziftomenib in combination with standard therapies for adults with specific genetic mutations that often lead to AML. These mutations include NPM1 and KMT2A. The data to be shared during the meeting will offer insights into both newly diagnosed patients undergoing treatment and those who have relapsed or have refractory forms of the disease.

ASH Presentation Highlights

The oral presentations at ASH will highlight key findings, including longer follow-ups and a comprehensive safety assessment from the trial. Notably, the outcomes being presented are derived from a data cutoff as of June 2025, ensuring they represent the most current research.

Combination Therapy Results

One of the abstracts focuses on the combination of ziftomenib with venetoclax and azacitidine for patients with either relapsed or refractory NPM1-m or KMT2A-r AML. This session, set for December 8, will delve into updated safety and clinical activity results, emphasizing the importance of combining established therapies with novel treatments like ziftomenib.

New Diagnoses Presentation

Additionally, the second presentation will cover the use of ziftomenib in patients newly diagnosed with NPM1-m AML. This session aims to showcase the efficacy of this combination therapy in early-stage treatment, potentially altering the course of AML therapy.

Expert Insights from Kura Oncology

Dr. Mollie Leoni, the Chief Medical Officer at Kura, expressed enthusiasm for the upcoming presentations. She emphasized the commitment to advancing menin inhibition therapies, aimed at benefiting a broader patient population in need. The KURA team is eager to share data from these trials, confident that ziftomenib represents a significant step forward in AML treatment, provided initial findings continue to hold true.

Kura's Dedication to Cancer Treatment Innovations

Kura Oncology is dedicated to developing precision medicines for challenging cancers. With a strong focus on small molecule drug candidates, their pipeline is designed to address both hematologic malignancies and solid tumors. The advancements in menin inhibition aim to improve outcomes for patients suffering from acute leukemias.

Engagement with the Hematology Community

Kura Oncology's collaboration with Kyowa Kirin highlights their commitment to providing innovative therapies that can change lives. By actively participating in key conferences like ASH, they engage with the broader hematology community, sharing insights and advancements that can ultimately lead to improved patient care.

About Kura Oncology and Kyowa Kirin

Kura is recognized as a clinical-stage biopharmaceutical company committed to developing targeted cancer treatments. With ziftomenib at the forefront of their pipeline, Kura exemplifies dedication to advancing therapies tailored to specific genetic vulnerabilities in cancer.

Kyowa Kirin, a prominent player in pharmaceutical innovation, has a rich history of discovery and development in biotechnology, consistently striving to create treatments that deliver substantial benefits to patients.

Frequently Asked Questions

What is the KOMET-007 trial?

The KOMET-007 trial is a Phase 1a/b study that evaluates ziftomenib in combination with standard therapies for adults with specific genetic mutations leading to AML.

When will the results from the trial be presented?

The results will be presented at the American Society of Hematology (ASH) 2025 Annual Meeting on December 8, 2025.

What are the expected findings from ASH?

The findings will focus on safety and efficacy results of ziftomenib in combination with other treatments for both newly diagnosed and relapsed AML patients.

Who is leading Kura Oncology?

Dr. Mollie Leoni serves as the Chief Medical Officer at Kura Oncology, leading the company's efforts in clinical development.

How can I learn more about Kura's research?

For more detailed information, you can visit Kura's official website or follow them on their social media platforms.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 171

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 90

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 25

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
AR Cards in Casino Gaming: A High-Stakes Revolution

Updated Category News Views 31

A New Breed of Casino Experience Walk into a casino today, and you might just enter a whole new reality. No, this isn’t a cheesy magician’s trick or a glitzy PR stunt—this is the real deal brought to you by augmented reality (AR) trading cards. Imagine the slots you love wrapped in a sci-fi movie where characters leap out, tap you on the shoulder, and call you by...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 95

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 124

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
Sivers Semiconductors: Strategy Behind 2027 AGM Plans

Updated Category News Views 234

Setting the Stage for a Crucial Year Ah, the dance of corporate governance—an arena where maneuvering is an art. Sivers Semiconductors AB, a name that's becoming synonymous with innovation in the photonics and wireless solutions sector, is prepping for its 2027 Annual General Meeting. Ahead of this pivotal event, they're forming a Nomination Committee to shape future...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 39

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 148

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 63

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading

Top 5 Most Recently Viewed Articles

Stellus Capital Achieves Milestone with 52-Week High Stock Surge

Updated Category News Views 254

Stellus Capital Achieves 52-Week High Stock Performance Stellus Capital Investment Corporation (NYSE: SCM) has recently marked a noteworthy milestone, with its stock soaring to a remarkable 52-week high of $14.7. This significant rise demonstrates the company’s robust growth trajectory and strategic maneuvers in the financial market. Stellus Capital has effectively...

Continue Reading
Key Market Movements Amid Global Economic Developments

Updated Category News Views 276

An Overview of Current Market Dynamics As we delve into the latest market trends, the dollar has recently experienced a notable decline, marking its lowest point of the year. This downturn is primarily attributed to the Bank of Japan's long-anticipated interest rate hike, which has shifted investor sentiments across the globe. Concurrently, the euro zone has shown...

Continue Reading
Zain Bahrain Claims Top Award for Outstanding Customer Engagement

Updated Category News Views 207

Zain Bahrain Claims Best-Connected Customer Experience Award Zain Bahrain, a major player in the telecommunications field, has recently been honored with the prestigious award for Best-Connected Customer Experience from IST Networks and Genesys. This remarkable recognition, awarded during LEAP, celebrates Zain Bahrain's remarkable journey in enhancing customer engagement...

Continue Reading
Insurance Crisis in America: Florida and California Impacted

Updated Category News Views 250

Alarming Insurance Trends in Florida and California The insurance landscape in certain parts of the United States is undergoing drastic changes. Recent analyses depict a troubling picture for homeowners in Florida and California, where reports show that a significant number of policyholders are being dropped by their insurance companies at an unprecedented rate. Florida...

Continue Reading
Axis Capital Achieves Record Stock High at $88.45

Updated Category News Views 134

Axis Capital's Remarkable Stock Performance In a stunning display of financial strength, Axis Capital Holdings Limited (NYSE: AXS) has achieved a groundbreaking stock price of $88.45, marking a historic milestone for the company. This surge reflects the robust growth that AXS has experienced over the past year, with a remarkable 59.47% increase noted in its stock...

Continue Reading